Clinical benefit of tunnel endoscopic submucosal dissection for esophageal squamous cancer: a multicenter, randomized controlled trial
Xiaotong Fan,Qi Wu,Rui Li,Weifeng Chen,Huaping Xie,Xin Zhao,Shaohua Zhu,Caixia Fan,Jianyi Li,Mei Liu,Zhiguo Liu,Ying Han
DOI: https://doi.org/10.1016/j.gie.2022.04.016
IF: 10.396
2022-04-01
Gastrointestinal Endoscopy
Abstract:Background and AimsEndoscopic submucosal dissection (ESD) is widely accepted as a primary treatment modality for dysplastic and early cancerous lesions of the gastrointestinal tract. However, prolonged procedure time and life-threatening adverse events remain obstacles to the successful treatment of esophageal cancer. The study aimed was to compare the efficacy and safety of tunnel endoscopic submucosal dissection (T-ESD) with conventional ESD (C-ESD) for superficial esophageal squamous neoplasms.MethodsA prospective, multicenter trial was conducted at five hospitals in China. Patients with esophageal squamous neoplasms were enrolled and randomly assigned to undergo C-ESD or T-ESD. Randomization was stratified by tumor location and circumference extent (< or ≥ 1/2). The primary endpoint was procedure time.ResultsBetween January and July 2018, 160 patients were enrolled. One hundred fifty-two patients (76 in the C-ESD group and 76 in the T-ESD group) were included in the final analysis. The median procedure time was 47.3 min (IQR, 31.7 – 81.3 min) and 40.0 min (IQR, 30.0 – 60.0 min) for C-ESD and T-ESD, respectively (P = 0.095). However, T-ESD specifically reduced the median procedure time to 34.5% (29.5 min) compared with C-ESD for lesions ≥ 1/2 circumference (P < 0.001). Among the multiple secondary outcomes, the muscular injury was less frequent in the T-ESD group compared to the C-ESD group (18.4% vs. 38.2%, P = 0.007), complete healing of artificial mucosal defect in one-month follow-up was more common in the T-ESD group than c- ESD group (95.9% vs. 84.7%, P = 0.026).ConclusionOur study suggests that tunnel ESD results in shorter procedure time, specifically for lesions ≥ 1/2 circumference of the esophagus. Besides, T-ESD has a better safety profile indicated by less frequent muscular injury and improved healing of artificial mucosal defects caused by ESD procedures.
gastroenterology & hepatology